Appointment of M/s. KPMG Assurance and Consulting Services LLP as Internal Auditors of the Company from FY 2026-27 up to FY 2028-29.
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
MPS Limited held its Board meeting on 15 May 2026 and approved the audited financial results for Q4 and FY ended March 2026. The statutory auditors, Walker Chandiok & Co LLP, issued an unmodified opinion on the results. The Board decided NOT to recommend a final dividend for FY 2025-26, citing that cash flow was deployed towards the acquisition of Unbound Medicine, Inc. completed on 9 February 2026. The company appointed KPMG Assurance and Consulting Services LLP as Internal Auditors for 3 years (FY 2026-27 to FY 2028-29) for both the company and its material subsidiary MPS Interactive Systems Limited, to align internal audit frameworks across the group. Walker Chandiok & Co LLP was also re-appointed as statutory auditors for another 5-year term subject to shareholder approval.
No dividend for FY 2025-26 may disappoint income-focused shareholders, but the company cited capital retention for growth. Appointment of a Big 4 firm (KPMG) as internal auditor signals improved governance. The company completed a significant acquisition (Unbound Medicine) in February 2026, which likely impacted cash position.